Company intelligence / Profile preview
BioCytics
Huntersville, North Carolina, United Statesbiocytics.com ↗
- Ownership
- Private
- Employees
- ~30
- Development stage
- Preclinical
01
Overview
BioCytics is developing autologous immune cell therapies for solid tumor cancers. Their lead program, BCyIF1, is advancing toward IND submission with support from a ScaleReady G-Rex grant to optimize cGMP manufacturing. The company collaborates on translational research and biospecimen banking but has not yet initiated patient infusions or received FDA approval for its products.
- Therapeutic areas
- Oncology
- Modalities
- Autologous immune cell therapiesCellular therapies (immune cell fractions)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Carolina BioOncology Institute Cancer Research ClinicNational Minority Quality Forum & Carolina BioOncology Institute—collaboration on national registry and biorepository for cancer risk factors in underserved communitiesScaleReady G-Rex Grant Program—for manufacturing optimization support
Beyond the preview
Go deeper on BioCytics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioCytics.